XIENCE V 1009541-23Recalls & reported problems
Abbott Vascular Inc. · XIENCE V Everolimus Eluting Coronary Stent System 3.00 mm x 23 mm / Rapid-Exchange · Class 3 · Implant
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 1
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08717648064135), received between Aug 11, 2016 and Aug 11, 2016 — classified as 1 death.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Angina1
- Death1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
DeathAug 11, 2016Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PROCEDURE ON (B)(6) 2010 WAS TO TREAT THREE LESIONS. A 3.5 X 28 MM XIENCE V STENT WAS IMPLANTED IN THE PROXIMAL RIGHT CORONARY ARTERY. A 3.0 X 23 MM XIENCE V STENT WAS IMPLANTED IN THE MID LEFT ANTERIOR DESCENDING ARTERY AND A NON-ABBOTT STENT WAS IMPLANTED IN THE LEFT MAIN ARTERY. ON (B)(6) 2010 FOLLOW-UP ANGIOGRAPHY WAS PERFORMED AND NO SYMPTOMS WERE NOTED. THE PATIENT WAS COMPLIANT WITH DUAL ANTIPLATELET THERAPY (DAPT). ON (B)(6) 2014 THE PATIENT PRESENTED WITH ANGINA. IT IS UNKNOWN IF TREATMENT WAS PERFORMED. ON (B)(6) 2015 FOLLOW-UP ANGIOGRAPHY WAS PERFORMED AND NO SYMPTOMS WERE NOTED. DAPT HAD BEEN STOPPED ON (B)(6) 2010. ON (B)(6) 2015 THE PATIENT EXPIRED. THE CAUSE OF DEATH IS UNKNOWN. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Angina; Death
MAUDE report 5869800 ↗
Other Coronary drug-eluting stent devices
- SYNERGY™ H7493926038300Boston Scientific Corporation · Coronary drug-eluting stent8 deaths124 reports
- SYNERGY™ H7493926016300Boston Scientific Corporation · Coronary drug-eluting stent7 deaths106 reports
- SYNERGY™ H7493926020300Boston Scientific Corporation · Coronary drug-eluting stent9 deaths90 reports
- XIENCE Sierra™ 1550350-33Abbott Vascular Inc. · Coronary drug-eluting stent1 recall32 reports
- SYNERGY™ H7493926016250Boston Scientific Corporation · Coronary drug-eluting stent6 deaths82 reports
- Resolute Onyx™ RONYX30022UXMedtronic, Inc. · Coronary drug-eluting stent6 deaths76 reports
- SYNERGY™ H7493926024300Boston Scientific Corporation · Coronary drug-eluting stent3 deaths75 reports
- Resolute Onyx™ RONYX30015UXMedtronic, Inc. · Coronary drug-eluting stent3 deaths73 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page